Login / Signup

Improved neurological function in a patient with complete spinal cord injury through bone marrow mesenchymal stem cells implantation: a case report.

Ying-Chuan KuanShinn-Zong LinTsung-Lang ChiuHsiang-Yi Hung
Published in: Regenerative medicine (2023)
Aim: Spinal cord injury (SCI) can cause severe disability. Several clinical trials of stem-cell based therapies are ongoing. We describe our experience of bone marrow mesenchymal stem cell (BMSC) therapy in a patient with complete SCI in the chronic stage. Case report: A 25-year-old man with complete SCI at T6 level presented with paraplegia for 5 years. We transplanted autologous BMSCs intramedullary. After 12 months follow-up, his Barthel index score was noticeably improved from severe to moderate dependency, and the sensation level improved from T7 to S5, but no improvement of motor function. Conclusion: Autologous BMSCs are potentially safe for patients with complete SCI in the chronic stage and may improve neurological function and quality of life.
Keyphrases
  • spinal cord injury
  • bone marrow
  • case report
  • spinal cord
  • mesenchymal stem cells
  • neuropathic pain
  • stem cells
  • clinical trial
  • early onset
  • multiple sclerosis
  • drug induced
  • high intensity